J&J Comes Under FDA Scrutiny: Reports
NEW YORK (
) --
Johnson & Johnson
(JNJ) - Get Report
continues to suffer from manufacturing problems that are drawing the attention of regulators, according to published media reports.
The company's McNeil Consumer Healthcare unit, which has been forced to make multiple recalls of medicines this year, has a variety of problems at a plant in Puerto Rico, according to a Food and Drug Administration inspection report that was the focus of articles in
The New York Times
and
The Wall Street Journal
on Friday and Saturday, respectively.
Among other problems, the Puerto Rico plant distributed drugs that failed to meet quality requirements, failed to spot product defects during tests and didn't detect incorrect expiration dates on drug labels, according to the
The New York Times
.
The inspection report was posted on the FDA's Web site earlier this month.
A representative for McNeil said the company had responded in detail to the agency's concerns, the
Times
reported.
McNeil and its parent had been trying to restore consumer trust after product recalls earlier this year, but they suffered another setback this week when
McNeil recalled 9.3 million bottles of three Tylenol products
.
Shares of Johnson & Johnson closed Friday down 86 cents at $62.43.
This article was written by a staff member of TheStreet.
